1. Home
  2. IRIX vs CELU Comparison

IRIX vs CELU Comparison

Compare IRIX & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.12

Market Cap

18.2M

Sector

Health Care

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$0.73

Market Cap

17.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRIX
CELU
Founded
1989
2016
Country
United States
United States
Employees
N/A
115
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2M
17.3M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
IRIX
CELU
Price
$1.12
$0.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
39.0K
168.4K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
51.85
N/A
EPS
N/A
N/A
Revenue
$41,593,000.00
N/A
Revenue This Year
$3.07
N/A
Revenue Next Year
$6.66
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$0.56
52 Week High
$1.65
$4.35

Technical Indicators

Market Signals
Indicator
IRIX
CELU
Relative Strength Index (RSI) 48.13 47.55
Support Level $1.01 $0.69
Resistance Level $1.18 $0.96
Average True Range (ATR) 0.04 0.08
MACD -0.01 0.01
Stochastic Oscillator 0.00 53.22

Price Performance

Historical Comparison
IRIX
CELU

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About CELU Celularity Inc.

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Share on Social Networks: